Hayfin Capital Management is an independent investment firm headquartered in London that provides lending solutions to European middle-market companies and asset management services to institutional clients. Founded in 2009, it operates a European-focused platform with offices in London, Paris, Madrid, Frankfurt, Amsterdam, Luxembourg and Tel Aviv, and maintains a growing presence in the United States with New York. The firm concentrates on four credit strategies: Direct Lending, Special Opportunities, High-Yield Credit and Securitized Credit. It emphasizes value investing through rigorous analysis and disciplined investing, with a network-driven origination approach and specialized teams in healthcare, shipping and real estate to manage complex restructurings, workouts and liquidations. Hayfin aims to deliver risk-adjusted returns for investors and attract talented professionals across its markets.
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
HeartFlow
Series F in 2023
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.